Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05944796
Other study ID # CamiloJcUDL
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 20, 2024
Est. completion date June 30, 2024

Study information

Verified date April 2024
Source Camilo Jose Cela University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diathermy, a therapy that uses deep heat to reach deep tissue layers, is known to induce the breaking down of fatty cells and fibrotic tissue. In lipedema, patients develop fibrosis of their subcutaneous adipose tissue. Therefore, diathermy could be an interesting tool to treat this disease. To test the effectiveness of diathermy on these patients, the investigators will select women with lipedema (18 to 70 yo) and place them in two groups (experimental and control group). The experimental group will receive the treatment, that is, 10 minutes of diathermy on the medial knee surface of both knees, with an intensity that produces heat just below the participants' pain threshold. Participants from the control group will receive sham diathermy, that is, placebo. The intervention consists of 10 sessions, 3 times a week, for 4 weeks. Researchers will collect data pre and post intervention and one month after the intervention ends. Data will consist of measurements at knee level with tape and an ultrasound device, pain threshold with an algometer, a VAS score and an SF-12 questionnaire for quality of life.


Description:

The goal of this clinical trial is to test the effectiveness of diathermy in reducing the subcutaneous adipose tissue affected by lipedema in women suffering from this disorder. The main questions it aims to answer are: - Does diathermy produce changes in subcutaneous adipose tissue affected by lipedema? - Is it effective as a tool for lipolysis and/or fibrolysis of said subcutaneous adipose tissue affected by lipedema? - Do these changes result in a reduction of subcutaneous adipose tissue affected by lipedema? - Do these changes decrease pain in the area treated with diathermy? Participants will: - Be assesed prior to receiving treatment: - Circometry of both knees (at joint space level) - Pain threshold using an algometer. Area: medial below knee region, at fibular head level - SF-12 questionnaire - VAS score - Ultrasound mesurements at medial collateral ligament (distance from skin to ligament) - Receive 10 diathermy sessions. 10 minutes per knee (medial knee surface), 3 times a week for 4 weeks. Parameters: 470 KHz, capacitive head, intensity: heat below pain threshold. - Be assesed after receiving treatment: - Circometry of both knees (at joint space level) - Pain threshold using an algometer. Area: medial below knee region, at fibular head level - SF-12 questionnaire - VAS score - Ultrasound mesurements at medial collateral ligament (distance from skin to ligament) - Be assesed after receiving treatment (one month post intervention): - Circometry of both knees (at joint space level) - Pain threshold using an algometer. Area: medial below knee region, at fibular head level - SF-12 questionnaire - VAS score - Ultrasound mesurements at medial collateral ligament (distance from skin to ligament) Researchers will compare an experimental group to a placebo group to see if treatment with diathermy is effective in reducing subcutaneous adipose tissue affected by lipedema.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date June 30, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - women between 18-70 years old. - Diagnosed with lipedema by a medical service. - Patients with type III or V lipedema (involvement of legs). - Patients with type II lipedema are also admitted if they have a fat pad on the inner side of the knee Exclusion Criteria: - Pregnant - Pacemaker or some other electronic implant - Metal implants or knee prostheses - Open wounds or burns on the inside of the knee - Thrombophlebitis - Malignant growths (cancer) - Infectious processes - Follow other non-conservative treatment related to lipedema at that time

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Diathermy
The patients belonging to the experimental group will undergo 10 diathermy sessions. The control group will have the same sessions but in athermy (placebo)
Placebo
The patients belonging to the placebo group will undergo 10 placebo sessions (athermya)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Camilo Jose Cela University

Outcome

Type Measure Description Time frame Safety issue
Primary Change of adipose tissue in the knee Using ultrasound, it is intended to know if a reduction in adipose tissue has occurred after the application of diathermy. baseline
Primary Change of adipose tissue in the knee Using ultrasound, it is intended to know if a reduction in adipose tissue has occurred after the application of diathermy. after finishing the treatment (one month)
Primary Change of adipose tissue in the knee Using ultrasound, it is intended to know if a reduction in adipose tissue has occurred after the application of diathermy. 30 days after finishing the treatment.
Primary Contour change in the knee. By using a tape measure, the circummetry of the knees on both sides will be assessed. The greater the contour, the more volume the patient will show. baseline
Primary Contour change in the knee. By using a tape measure, the circummetry of the knees on both sides will be assessed. The greater the contour, the more volume the patient will show. after finishing the treatment (one month)
Primary Contour change in the knee. By using a tape measure, the circummetry of the knees on both sides will be assessed. The greater the contour, the more volume the patient will show. 30 days after finishing the treatment.
Primary Quality of life (SF-12). SF-12 quality of life questionnaire. The higher the score obtained in the questionnaire, the better the patient's quality of life. The maximum value that can be reached is 100 and the minimum is 0. baseline
Primary Quality of life (SF-12). SF-12 quality of life questionnaire. The higher the score obtained in the questionnaire, the better the patient's quality of life. The maximum value that can be reached is 100 and the minimum is 0. after finishing the treatment (one month)
Primary Quality of life (SF-12). SF-12 quality of life questionnaire. The higher the score obtained in the questionnaire, the better the patient's quality of life. The maximum value that can be reached is 100 and the minimum is 0. 30 days after finishing the treatment.
Primary Measure pain Visual analogic scale (VAS). The higher the visual analogue scale score, the more pain the patient presents. The maximum value that can be reached is 10 and the minimum is 0. baseline
Primary Measure pain Visual analogic scale (VAS). The higher the visual analogue scale score, the more pain the patient presents. The maximum value that can be reached is 10 and the minimum is 0. after finishing the treatment (one month)
Primary Measure pain Visual analogic scale (VAS). The higher the visual analogue scale score, the more pain the patient presents. The maximum value that can be reached is 10 and the minimum is 0. 30 days after finishing the treatment.
Primary Algometry. Using the algometer, pain sensitivity will be assessed when pressing medial infracondylar leg at the level of the fibular head. The lower the algometry score, the more pain the patient will have. The maximum value that can be reached is 5 and the minimum value is 0. baseline
Primary Algometry. Using the algometer, pain sensitivity will be assessed when pressing medial infracondylar leg at the level of the fibular head. The lower the algometry score, the more pain the patient will have. The maximum value that can be reached is 5 and the minimum value is 0. after finishing the treatment (one month)
Primary Algometry. Using the algometer, pain sensitivity will be assessed when pressing medial infracondylar leg at the level of the fibular head. The lower the algometry score, the more pain the patient will have. The maximum value that can be reached is 5 and the minimum value is 0. 30 days after finishing the treatment.
Secondary Sociodemographic variables Sociodemographic data such as age, weight, height and marital status will be collected baseline.
See also
  Status Clinical Trial Phase
Completed NCT04492046 - Complex Decongestive Applications in Patients With Lipedema
Completed NCT04643392 - Physiotherapy Applications in Upper Extremity Lipedema
Recruiting NCT05464927 - Visualizing Vascular Mechanisms of Lipedema
Completed NCT02907411 - Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS) N/A
Completed NCT06238791 - Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
Completed NCT03710798 - Effect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema N/A
Completed NCT03758651 - Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
Not yet recruiting NCT04166084 - Trunk Stabilization Exercises at Lipoedema Patients N/A
Recruiting NCT05628948 - Vascular Lab Resource (VLR) Biorepository
Completed NCT05616962 - Collected Data of Medical Food, Vasculera or Diosmiplex, in Clinic Patients 20 to 70 Years Old Diagnosed With Lipedema N/A
Active, not recruiting NCT04632810 - Effect of Ketosis on Pain and Quality of Life in Patients With Lipedema N/A
Recruiting NCT05284266 - The National Lipedema Study N/A
Active, not recruiting NCT06338059 - Relationship Between Vitamin D and Vitamin B12 Levels and Neuropathic Pain in Lipedema
Completed NCT04076891 - Treatment of Women With Lipedema Involving Substantial Fat Above the Knee or of Women and Men With Nodular Dercum's Disease Phase 2
Completed NCT03492840 - Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease Phase 2
Recruiting NCT02838277 - Insight Into Subcutaneous Adipose Tissue Disorders N/A
Completed NCT05966779 - Physical Therapy in Lipedema Surgery
Recruiting NCT05488977 - The Effects of Endurance Training on Lipedema N/A
Completed NCT04213989 - Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling) N/A
Enrolling by invitation NCT00833599 - Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders